Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature's Bounty
- PMID: 32076618
- PMCID: PMC7013350
- DOI: 10.1155/2020/8602879
Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature's Bounty
Abstract
Medicinal plants have been used from the beginning of human civilization, which is mostly evident from the ancient script and traditional herbal medicine recipe. Despite the historically enriched demonstration about the use of plant as therapeutics, the pharmaceutical industries lack interest on phytochemical research compared with synthetic drug. Mostly, the absence of information about plant-based medicinal therapeutics is responsible to draw the attention of researchers to think about natural products as potential drug for detrimental diseases, such as cancer. This review will cover about clinically successful plant-based anticancer drugs and underappreciated, but potential, drugs to bridge the information gap between plant biologists and clinical researchers. Additionally, unprecedented advancement of synthetic chemistry, omics study to pin point the target genes/proteins, and efficient drug delivery system have made it easier for researchers to develop a phytochemical as an efficient anticancer drug.
Copyright © 2020 Mohammad Arif Ashraf.
Conflict of interest statement
The author declares that there are no conflicts of interest regarding the publication of this paper.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
